Chemotherapy News and Research

Latest Chemotherapy News and Research

Carvedilol improves heart health marker in childhood cancer survivors

Physicians at City of Hope, one of the largest cancer research and treatment organizations in the United States, in cooperation with the Children's Oncology Group (COG), have conducted the largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure.

9 Jan 2024

Zika virus effective in eliminating neuroblastoma tumors in mice, study finds

Injecting neuroblastoma tumors with Zika virus shrank or eliminated those tumors in studies with mice, suggesting that the virus could someday serve as an effective cancer therapy, according to a study led by Nemours Children's Health researchers and published today in Cancer Research Communications, a journal of the American Association for Cancer Research.

9 Jan 2024

Children with neuroblastomas may benefit from new drug cocktail

Children who develop neuroblastomas, a rare form of cancer which develops in nerve cells, may benefit from receiving certain anti-tumor drugs as well as chemotherapy, a new trial has found.

9 Jan 2024

Amino acid nanoparticles show promise for cancer treatment

Amino acids, such as tyrosine and tryptophan, are the fundamental building blocks that make up proteins.

8 Jan 2024

Research potentially expands options for patients with aggressive childhood cancer

Research is shedding light and potentially expanding options for patients living with Medulloblastoma, an aggressive childhood cancer.

8 Jan 2024

Combining immunotherapy and radiation to tackle aggressive triple-negative breast cancer

Cedars-Sinai Cancer investigators have analyzed the cells within triple-negative breast cancer tumors before and after radiation therapy with immunotherapy, identifying three patient groups with different responses to the treatment.

8 Jan 2024

UCSF research lays the groundwork for preventing deafness

Researchers have found a gene that links deafness to cell death in the inner ear in humans – creating new opportunities for averting hearing loss.

8 Jan 2024

Growing tiny tumors in the lab for personalized lung cancer treatment

Lung cancer accounts for nearly 20% of annual cancer-related deaths worldwide. According to 2022 statistics from the Swiss Cancer League, nearly 5,000 new cases of lung cancer are reported in Switzerland each year.

8 Jan 2024

Stapled lipopeptides show promise as broad-spectrum antiviral agents

Compounds that obstruct the "landing gear" of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19, a study published today and led by Dana-Farber Cancer Institute scientists shows.

5 Jan 2024

Breakthrough drug halts lung cancer and brain metastases

D'Or Institute for Research and Education (IDOR) played an important role in the phase III LIBRETTO-431 multicenter study, which evaluated the efficacy and safety of selpercatinib compared to control treatment, which consisted of platinum-based chemotherapy associated or not with pembrolizumab (immune checkpoint inhibitor) in non-small cell lung cancer (NSCLC).

5 Jan 2024

High-resolution map of the neuroblastoma immune landscape points to new target for immunotherapy

A detailed 'atlas' of neuroblastoma tumors points to a new target for immunotherapy. Scientists from the Princess Máxima Center for Pediatric Oncology in the Netherlands mapped this childhood tumor at the level of individual cancer and immune cells.

4 Jan 2024

Researchers receive $2.4 million grant to validate new blood test for early breast cancer detection

Weill Cornell Medicine researchers received a $2.4 million grant from the U.S. Department of Defense Breast Cancer Research Program to validate a new blood test for the early detection of breast cancer.

3 Jan 2024

How Artificial General Intelligence can transform radiation oncology

This paper provides an overview of how Artificial General Intelligence (AGI) can transform radiation oncology to elevate the standard of patient care, with the key insight being AGI's ability to exploit multimodal clinical data at scale.

3 Jan 2024

68Ga-FAPI PET imaging superior to existing methods for detecting pancreatic cancer

PET imaging with 68Ga-FAPI can more effectively detect and stage pancreatic cancer as compared with 18F-FDG imaging or contrast-enhanced CT, according to new research published in the December issue of The Journal of Nuclear Medicine.

2 Jan 2024

$15 million NCI grant awarded to investigate a type of radiation therapy for hard-to-treat cancers

The Radiopharmaceutical Therapy and Dosimetry Lab at Johns Hopkins Medicine, headed by George Sgouros, Ph.D., has been awarded a $15 million grant, to be dispersed over the next five years, from the National Cancer Institute at the National Institutes of Health.

28 Dec 2023

$Lisocabtagene maraleucel: A cost-effective second-line treatment for relapsed/refractory DLBCL$

Lisocabtagene maraleucel: A cost-effective second-line treatment for relapsed/refractory DLBCL

Lisocabtagene maraleucel (liso-cel), a CAR T-cell therapy, is a cost effective second line treatment for relapsed and refractory (hard to treat) diffuse large B-cell lymphoma (r/r DLBCL), according to a study published today in Blood Advances.

28 Dec 2023

In year 6, KFF Health News-NPR’s ‘Bill of the Month’ helps patients in a changing system

In 2023, our nationwide reporting team has been hard at work on a holiday gift to you: a packet of advice for navigating the labyrinthine American medical system.

26 Dec 2023

Brazilian review explores emerging therapies for advanced Hodgkin lymphoma

A new review paper was published in Oncotarget's Volume 14 on December 12, 2023, entitled, "Current perspectives on the management of refractory or relapsed classic Hodgkin lymphoma in Brazil: Balancing efficacy, safety, and tolerability."

20 Dec 2023

Gamma stimulation may improve memory and cognition in people with Alzheimer's disease

A surprising MIT study published in Nature at the end of 2016 helped to spur interest in the possibility that light flickering at the frequency of a particular gamma-band brain rhythm could produce meaningful therapeutic effects for people with Alzheimer's disease.

20 Dec 2023

Forsythiae Fructus shows promise in relieving chemotherapy side effects

Chemotherapy-induced nausea and vomiting (CINV) are among the most prevalent and distressing side effects faced by patients undergoing antineoplastic treatments.

19 Dec 2023

Chemotherapy News and Research

Latest Chemotherapy News and Research

Carvedilol improves heart health marker in childhood cancer survivors

Zika virus effective in eliminating neuroblastoma tumors in mice, study finds

Children with neuroblastomas may benefit from new drug cocktail

Amino acid nanoparticles show promise for cancer treatment

Research potentially expands options for patients with aggressive childhood cancer

Combining immunotherapy and radiation to tackle aggressive triple-negative breast cancer

UCSF research lays the groundwork for preventing deafness

Growing tiny tumors in the lab for personalized lung cancer treatment

Stapled lipopeptides show promise as broad-spectrum antiviral agents

Breakthrough drug halts lung cancer and brain metastases

High-resolution map of the neuroblastoma immune landscape points to new target for immunotherapy

Researchers receive $2.4 million grant to validate new blood test for early breast cancer detection

How Artificial General Intelligence can transform radiation oncology

68Ga-FAPI PET imaging superior to existing methods for detecting pancreatic cancer

$15 million NCI grant awarded to investigate a type of radiation therapy for hard-to-treat cancers

Lisocabtagene maraleucel: A cost-effective second-line treatment for relapsed/refractory DLBCL

In year 6, KFF Health News-NPR’s ‘Bill of the Month’ helps patients in a changing system

Brazilian review explores emerging therapies for advanced Hodgkin lymphoma

Gamma stimulation may improve memory and cognition in people with Alzheimer's disease

Forsythiae Fructus shows promise in relieving chemotherapy side effects

Cancer Research eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in